MYO Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | Kovelman Harry | officer: Chief Medical Officer | 133,581 | F-InKind | D | 146 | 2.97 | 433.60 |
| 2024-03-26 | Getz Heather C | 0 | 0 | 0.00 | 0.00 | |||
| 2024-03-14 | KIRK THOMAS F | director | 186,499 | P-Purchase | A | 50,000 | 3.50 | 175,000.00 |
| 2024-03-11 | HENRY DAVID A | officer: Chief Financial Officer | 344,419 | F-InKind | D | 7,774 | 3.51 | 27,287.00 |
| 2024-03-11 | Kovelman Harry | officer: Chief Medical Officer | 133,727 | F-InKind | D | 6,590 | 3.51 | 23,131.00 |
| 2024-03-11 | Mitchell Micah | officer: Chief Commercial Officer | 156,435 | F-InKind | D | 5,359 | 3.51 | 18,810.00 |
| 2024-03-05 | Kovelman Harry | officer: Chief Medical Officer | 140,317 | F-InKind | D | 147 | 3.88 | 570.40 |
| 2024-02-05 | Kovelman Harry | officer: Chief Medical Officer | 140,464 | F-InKind | D | 146 | 3.21 | 468.70 |
| 2024-01-19 | Morris Milton Mayo | director | 102,933 | A-Award | A | 25,000 | 3.80 | 95,000.00 |
| 2023-08-29 | HENRY DAVID A | officer: Chief Financial Officer | 352,193 | A-Award | A | 41,666 | 0.60 | 25,000.00 |
| 2023-08-29 | Kovelman Harry | officer: Chief Medical Officer | 149,556 | A-Award | A | 8,333 | 0.60 | 5,000.00 |
| 2024-01-03 | Kovelman Harry | officer: Chief Medical Officer | 140,610 | F-InKind | D | 145 | 4.69 | 680.10 |
| 2023-11-20 | KIRK THOMAS F | director | 136,499 | P-Purchase | A | 50,000 | 3.10 | 155,000.00 |
| 2023-12-08 | Crowley Thomas Aloysius Jr. | director | 29,994 | S-Sale | D | 14,997 | 4.08 | 61,188.00 |
| 2023-12-01 | Kovelman Harry | officer: Chief Medical Officer | 140,854 | S-Sale | D | 8,333 | 3.12 | 26,016.00 |
| 2023-12-05 | Kovelman Harry | officer: Chief Medical Officer | 140,755 | F-InKind | D | 99 | 4.02 | 398.00 |
| 2023-11-28 | Crowley Thomas Aloysius Jr. | director | 45,001 | S-Sale | D | 14,997 | 3.27 | 49,040.00 |
| 2023-11-06 | Kovelman Harry | officer: Chief Medical Officer | 149,187 | F-InKind | D | 121 | 1.41 | 170.60 |
| 2023-10-03 | Kovelman Harry | officer: Chief Medical Officer | 149,308 | F-InKind | D | 123 | 1.10 | 135.30 |
| 2023-09-08 | Morris Milton Mayo | director | 77,933 | P-Purchase | A | 15,000 | 1.06 | 15,867.00 |
| 2023-09-05 | Kovelman Harry | officer: Chief Medical Officer | 149,431 | F-InKind | D | 125 | 0.87 | 108.80 |
| 2023-08-30 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 878,245 | P-Purchase | A | 48,400 | 0.74 | 36,039.00 |
| 2023-08-29 | Kovelman Harry | officer: Chief Medical Officer | 149,556 | P-Purchase | A | 8,333 | 0.60 | 5,000.00 |
| 2023-08-29 | HENRY DAVID A | officer: Chief Financial Officer | 352,193 | P-Purchase | A | 41,666 | 0.60 | 25,000.00 |
| 2023-08-29 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 829,845 | P-Purchase | A | 37,000 | 0.78 | 28,797.00 |
| 2023-08-28 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 792,845 | P-Purchase | A | 42,500 | 0.75 | 31,794.00 |
| 2023-08-03 | Kovelman Harry | officer: Chief Medical Officer | 141,223 | F-InKind | D | 125 | 0.71 | 88.75 |
| 2023-07-05 | Kovelman Harry | officer: Chief Medical Officer | 141,348 | F-InKind | A | 109 | 0.60 | 65.40 |
| 2023-06-28 | Mitchell Micah | officer: Chief Commerical Officer | 161,794 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2023-06-28 | Kovelman Harry | officer: Chief Medical Officer | 141,457 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2023-06-28 | HENRY DAVID A | officer: Chief Financial Officer | 310,527 | A-Award | A | 130,000 | 0.00 | 0.00 |
| 2023-06-28 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 750,345 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2023-06-28 | Morris Milton Mayo | director | 62,933 | A-Award | A | 59,988 | 0.00 | 0.00 |
| 2023-06-28 | Knapp Amy K. | director | 79,611 | A-Award | A | 59,988 | 0.00 | 0.00 |
| 2023-06-28 | KIRK THOMAS F | director | 86,499 | A-Award | A | 59,988 | 0.00 | 0.00 |
| 2023-06-28 | Crowley Thomas Aloysius Jr. | director | 59,988 | A-Award | A | 59,988 | 0.00 | 0.00 |
| 2022-06-06 | Crowley Thomas Aloysius Jr. | director | 9,401 | S-Sale | D | 3,500 | 2.29 | 8,001.00 |
| 2022-06-08 | Crowley Thomas Aloysius Jr. | director | 6,401 | S-Sale | D | 3,000 | 2.15 | 6,441.00 |
| 2022-06-09 | Crowley Thomas Aloysius Jr. | director | 6,291 | S-Sale | D | 110 | 2.15 | 236.10 |
| 2022-06-10 | Crowley Thomas Aloysius Jr. | director | 291 | S-Sale | D | 6,000 | 1.97 | 11,790.00 |
| 2022-06-14 | Crowley Thomas Aloysius Jr. | director | 0 | S-Sale | D | 291 | 1.67 | 485.40 |
| 2023-06-08 | Kovelman Harry | officer: Chief Medical Officer | 61,827 | F-InKind | D | 5,105 | 0.46 | 2,364.00 |
| 2023-06-09 | Kovelman Harry | officer: Chief Medical Officer | 61,328 | F-InKind | D | 499 | 0.46 | 230.10 |
| 2023-06-06 | Kovelman Harry | officer: Chief Medical Officer | 66,932 | F-InKind | D | 125 | 0.55 | 68.75 |
| 2023-05-03 | Kovelman Harry | officer: Chief Medical Officer | 67,057 | F-InKind | D | 131 | 0.55 | 72.05 |
| 2023-04-03 | Kovelman Harry | officer: Chief Medical Officer | 67,188 | F-InKind | D | 129 | 0.73 | 94.17 |
| 2023-03-08 | Mitchell Micah | officer: Chief Commerical Officer | 81,815 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | Kovelman Harry | officer: Chief Medical Officer | 67,317 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | HENRY DAVID A | officer: Chief Financial Officer | 180,527 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 500,345 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-03 | Kovelman Harry | officer: Chief Medical Officer | 50,317 | F-InKind | D | 130 | 0.62 | 80.60 |
| 2023-01-17 | Jacobovitz Yitzchak | director | 0 | I | 77,156 | 0.00 | 7.72 | |
| 2023-02-03 | Kovelman Harry | officer: Chief Medical Officer | 50,447 | F-InKind | D | 132 | 0.49 | 64.68 |
| 2023-01-17 | Mitchell Micah | officer: Chief Commerical Officer | 64,815 | P-Purchase | A | 15,384 | 0.33 | 5,000.00 |
| 2023-01-17 | HENRY DAVID A | officer: Chief Financial Officer | 163,527 | P-Purchase | A | 76,923 | 0.33 | 25,000.00 |
| 2023-01-17 | GUDONIS PAUL R | officer: Chief Executive Officer | 483,345 | P-Purchase | A | 307,692 | 0.33 | 100,000.00 |
| 2023-01-04 | Kovelman Harry | officer: Chief Medical Officer | 50,579 | F-InKind | D | 139 | 0.49 | 68.11 |
| 2022-12-05 | Kovelman Harry | officer: Chief Medical Officer | 50,718 | F-InKind | D | 126 | 0.66 | 83.16 |
| 2022-12-01 | KIRK THOMAS F | director | 26,513 | X-InTheMoney | A | 333 | 0.00 | 0.03 |
| 2022-12-01 | KIRK THOMAS F | director | 0 | X-InTheMoney | D | 333 | 0.00 | 0.00 |
| 2022-11-21 | GUDONIS PAUL R | officer: Chief Executive Officer | 175,653 | X-InTheMoney | A | 333 | 0.00 | 0.03 |
| 2022-11-21 | GUDONIS PAUL R | officer: Chief Executive Officer | 0 | X-InTheMoney | D | 333 | 0.00 | 0.00 |
| 2022-11-22 | HENRY DAVID A | officer: Chief Financial Officer | 86,604 | P-Purchase | A | 9,000 | 0.55 | 4,960.00 |
| 2022-11-03 | Kovelman Harry | officer: Chief Medical Officer | 50,844 | F-InKind | D | 125 | 1.37 | 171.20 |
| 2022-10-03 | Kovelman Harry | officer: Chief Medical Officer | 50,969 | F-InKind | D | 128 | 1.57 | 201.00 |
| 2022-09-06 | Kovelman Harry | officer: Chief Medical Officer | 51,097 | F-InKind | D | 128 | 1.76 | 225.30 |
| 2022-08-05 | Crowley Thomas Aloysius Jr. | director: | 12,901 | S-Sale | D | 7,141 | 1.71 | 12,218.00 |
| 2022-08-03 | Kovelman Harry | officer: Chief Medical Officer | 51,225 | F-InKind | D | 118 | 1.91 | 225.50 |
| 2022-07-05 | Kovelman Harry | officer: Chief Medical Officer | 51,343 | F-InKind | D | 127 | 1.64 | 208.30 |
| 2022-06-13 | Kovelman Harry | officer: Chief Medical Officer | 51,470 | F-InKind | D | 484 | 1.83 | 885.70 |
| 2022-06-13 | HENRY DAVID A | officer: Chief Financial Officer | 77,604 | F-InKind | D | 4,417 | 1.80 | 7,933.00 |
| 2022-06-13 | Mitchell Micah | officer: Chief Commerical Officer | 49,431 | F-InKind | D | 1,846 | 1.79 | 3,312.00 |
| 2022-06-08 | Mitchell Micah | officer: Chief Commerical Officer | 51,277 | A-Award | A | 28,000 | 0.00 | 0.00 |
| 2022-06-08 | Kovelman Harry | officer: Chief Medical Officer | 51,954 | A-Award | A | 28,000 | 0.00 | 0.00 |
| 2022-06-08 | HENRY DAVID A | officer: Chief Financial Officer | 82,021 | A-Award | A | 41,500 | 0.00 | 0.00 |
| 2022-06-08 | GUDONIS PAUL R | officer: Chief Executive Officer | 175,320 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2022-06-03 | Kovelman Harry | officer: Chief Medical Officer | 23,954 | F-InKind | D | 138 | 2.31 | 318.80 |
| 2022-05-20 | Mitchell Micah | officer: Chief Commerical Officer | 23,277 | A-Award | A | 7,424 | 0.00 | 0.00 |
| 2022-05-20 | Kovelman Harry | officer: Chief Medical Officer | 26,941 | A-Award | A | 6,987 | 0.00 | 0.00 |
| 2022-05-20 | Kovelman Harry | officer: Chief Medical Officer | 24,092 | F-InKind | D | 2,849 | 2.06 | 5,869.00 |
| 2022-05-20 | HENRY DAVID A | officer: Chief Financial Officer | 43,915 | A-Award | A | 8,297 | 0.00 | 0.00 |
| 2022-05-20 | HENRY DAVID A | officer: Chief Financial Officer | 40,521 | F-InKind | D | 3,394 | 2.06 | 6,992.00 |
| 2022-05-20 | GUDONIS PAUL R | officer: Chief Executive Officer | 100,320 | A-Award | A | 8,302 | 0.00 | 0.00 |
| 2022-05-03 | Kovelman Harry | officer: Chief Medical Officer | 19,954 | F-InKind | D | 134 | 3.03 | 406.00 |
| 2022-04-04 | Kovelman Harry | officer: Chief Medical Officer | 20,088 | F-InKind | D | 134 | 4.01 | 537.30 |
| 2022-03-14 | GUDONIS PAUL R | officer: Chief Executive Officer | 92,018 | P-Purchase | A | 5,000 | 4.22 | 21,085.00 |
| 2022-03-11 | GUDONIS PAUL R | officer: Chief Executive Officer | 87,018 | P-Purchase | A | 5,000 | 4.63 | 23,146.00 |
| 2022-03-07 | Kovelman Harry | officer: Chief Medical Officer | 20,222 | F-InKind | D | 131 | 7.22 | 945.80 |
| 2022-02-03 | Kovelman Harry | officer: Chief Medical Officer | 20,353 | F-InKind | D | 132 | 7.60 | 1,003.00 |
| 2022-01-03 | Kovelman Harry | officer: Chief Medical Officer | 20,485 | F-InKind | D | 125 | 7.22 | 902.50 |
| 2021-12-03 | Kovelman Harry | officer: Chief Medical Officer | 20,610 | F-InKind | D | 128 | 7.75 | 992.00 |
| 2021-11-16 | HENRY DAVID A | officer: Chief Financial Officer | 35,618 | P-Purchase | A | 1,000 | 8.86 | 8,855.00 |
| 2021-11-12 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 82,018 | P-Purchase | A | 1,000 | 9.86 | 9,858.00 |
| 2021-11-03 | Kovelman Harry | officer: Chief Medical Officer | 20,738 | F-InKind | D | 1,625 | 10.39 | 16,884.00 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 20,042 | M-Exempt | A | 211 | 0.05 | 10.13 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 19,831 | M-Exempt | A | 208 | 0.05 | 9.98 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 0 | M-Exempt | D | 208 | 0.05 | 9.98 |
| 2021-07-20 | Mitchell Micah | officer: Chief Commerical Officer | 17,238 | S-Sale | D | 5,745 | 9.02 | 51,820.00 |
| 2021-07-21 | Mitchell Micah | officer: Chief Commerical Officer | 15,853 | S-Sale | D | 1,385 | 9.01 | 12,479.00 |
| 2021-06-09 | Morris Milton Mayo | director | 2,945 | A-Award | A | 2,945 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
